These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38645718)

  • 21. The Increased Amyloidogenicity of Spike RBD and pH-Dependent Binding to ACE2 May Contribute to the Transmissibility and Pathogenic Properties of SARS-CoV-2 Omicron as Suggested by In Silico Study.
    Aksenova AY; Likhachev IV; Grishin SY; Galzitskaya OV
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant.
    Sevenich M; van den Heuvel J; Gering I; Mohrlüder J; Willbold D
    J Virol; 2022 Jul; 96(13):e0068522. PubMed ID: 35674432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.
    Rodriguez JA; Gonzalez J; Arboleda-Bustos CE; Mendoza N; Martinez C; Pinzon A
    Chem Biol Interact; 2022 Dec; 368():110244. PubMed ID: 36336003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Analysis of SARS-CoV-2 Variants of Concern, Including Omicron, Highlights Their Common and Distinctive Amino Acid Substitution Patterns, Especially at the Spike ORF.
    Nikolaidis M; Papakyriakou A; Chlichlia K; Markoulatos P; Oliver SG; Amoutzias GD
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment.
    Kumar S; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Oct; 94(10):4780-4791. PubMed ID: 35680610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
    Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T
    mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A computational evaluation of structural stability of omicron and delta mutations of SARS-CoV-2 spike proteins and human ACE-2 interactions.
    Idowu KA; Onyenaka C; Olaleye OA
    Inform Med Unlocked; 2022; 33():101074. PubMed ID: 36092780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes.
    Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Insights into the Variability in Infection and Immune Evasion Capabilities of SARS-CoV-2 Variants: A Sequence and Structural Investigation of the RBD Domain.
    Wang TH; Shao HP; Zhao BQ; Zhai HL
    J Chem Inf Model; 2024 Apr; 64(8):3503-3523. PubMed ID: 38517012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022.
    Nduwimana C; Nzoyikorera N; Ndihokubwayo A; Ihorimbere T; Nibogora C; Ndoreraho A; Hajayandi O; Bizimana JC; Diawara I; Niyonizigiye D; Nyandwi J
    BMC Genomics; 2023 Jun; 24(1):312. PubMed ID: 37301830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Silico Genome Analysis Reveals the Evolution and Potential Impact of SARS-CoV-2 Omicron Structural Changes on Host Immune Evasion and Antiviral Therapeutics.
    Chauhan D; Chakravarty N; Jeyachandran AV; Jayakarunakaran A; Sinha S; Mishra R; Arumugaswami V; Ramaiah A
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additional Positive Electric Residues in the Crucial Spike Glycoprotein S Regions of the New SARS-CoV-2 Variants.
    Pawłowski PH
    Infect Drug Resist; 2021; 14():5099-5105. PubMed ID: 34880635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Perspective for Emerging More Transmissible and Vaccine-Resistant Strains.
    de Souza AS; de Freitas Amorim VM; Guardia GDA; Dos Santos FF; Ulrich H; Galante PAF; de Souza RF; Guzzo CR
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic diversity and evolutionary dynamics of the Omicron variant of SARS-CoV-2 in Morocco.
    El Mazouri S; Essabbar A; Aanniz T; Eljaoudi R; Belyamani L; Ibrahimi A; Ouadghiri M
    Pathog Glob Health; 2024 May; 118(3):241-252. PubMed ID: 37635364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2.
    Fang L; Xu J; Zhao Y; Fan J; Shen J; Liu W; Cao G
    Front Microbiol; 2023; 14():1228128. PubMed ID: 37560529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semicovariance Coefficient Analysis of Spike Proteins from SARS-CoV-2 and Other Coronaviruses for Viral Evolution and Characteristics Associated with Fatality.
    Huang JS; Huang JM; Zhang W
    Entropy (Basel); 2021 Apr; 23(5):. PubMed ID: 33922613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.